Tenaya Therapeutics, Inc. (TNYA)
NASDAQ: TNYA · Real-Time Price · USD
2.410
+0.470 (24.23%)
At close: Nov 4, 2024, 4:00 PM
2.430
+0.020 (0.83%)
After-hours: Nov 4, 2024, 7:59 PM EST
Tenaya Therapeutics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Tenaya Therapeutics stock have an average target of 15.25, with a low estimate of 7.00 and a high estimate of 20. The average target predicts an increase of 532.78% from the current stock price of 2.41.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for TNYA stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 3 | 3 | 3 | 3 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $16 | Strong Buy | Maintains | $16 | +563.90% | Oct 18, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +646.89% | Oct 18, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +646.89% | Jul 8, 2024 |
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Jun 10, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $18 → $16 | Strong Buy | Maintains | $18 → $16 | +563.90% | May 16, 2024 |
Financial Forecast
Revenue This Year
850.00K
Revenue Next Year
3.91M
from 850.00K
Increased by 360.00%
EPS This Year
-1.52
from -1.68
EPS Next Year
-1.59
from -1.52
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 5.3M | 15.8M | 77.5M | ||
| Avg | 849,997 | 3.9M | 41.7M | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | 1,752.9% | 1,883.0% | ||
| Avg | - | 360.0% | 965.6% | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.45 | -1.48 | -0.83 | ||
| Avg | -1.52 | -1.59 | -1.56 | ||
| Low | -1.71 | -1.90 | -1.98 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.